Centro Médico Imbanaco

Cali 760042

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Crohn's Disease, SARS-CoV-2

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• FREEDOM COVID-19 Anticoagulation Strategy — Completed